Cargando…

Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics

Platinum drugs are among the most effective anticancer agents, but their mode of action is still not fully understood. We therefore carried out a systematic investigation on the cellular activities of cisplatin, carboplatin and oxaliplatin in A498 kidney cancer cells. Cytotoxicity was higher for cis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoch, Sarah, Gajewski, Sabine, Rothfuß, Jana, Hartwig, Andrea, Köberle, Beate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555145/ https://www.ncbi.nlm.nih.gov/pubmed/32967255 http://dx.doi.org/10.3390/ijms21186928

Ejemplares similares

In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based Compounds
por: Schoch, Sarah, et al.
Publicado: (2021)

Platinum Complexes in Colorectal Cancer and Other Solid Tumors
por: Köberle, Beate, et al.
Publicado: (2021)

Chemotherapeutic Agents for the Treatment of Hepatocellular Carcinoma: Efficacy and Mode of Action
por: Shaaban, Saad, et al.
Publicado: (2014)

Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
por: Gersten, Benjamin K., et al.
Publicado: (2020)

High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol
por: Deitersen, Jana, et al.
Publicado: (2021)

STATing the importance of immune modulation by platinum chemotherapeutics
por: Hato, Stanleyson V., et al.
Publicado: (2012)

Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
por: Ferraro, Maria Grazia, et al.
Publicado: (2022)

Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action
por: Dai, Ziwen, et al.
Publicado: (2020)

New Perfluorophtalate Complexes of Platinum(II) With Chemotherapeutic Potential
por: de Oliveira, M. B., et al.
Publicado: (1996)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms
por: Szikriszt, Bernadett, et al.
Publicado: (2021)

Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics—A Review
por: Stankovic, Jelena S. Katanic, et al.
Publicado: (2020)

The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics
por: Pan, Zhenrui, et al.
Publicado: (2023)

Mode of action-based risk assessment of genotoxic carcinogens
por: Hartwig, Andrea, et al.
Publicado: (2020)

Use of high-throughput RT-qPCR to assess modulations of gene expression profiles related to genomic stability and interactions by cadmium
por: Fischer, Bettina Maria, et al.
Publicado: (2015)

The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC
por: WANG, YA-DI, et al.
Publicado: (2011)

Relations between approved platinum drugs and non-coding RNAs in mesothelioma
por: Biersack, Bernhard
Publicado: (2018)

Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
por: Li, Bin, et al.
Publicado: (2014)

Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive Compounds()
por: Gorshkov, Kirill, et al.
Publicado: (2018)

The Tubercle Bacillus and Fundamental Chemotherapeutic and Antibiotic Action
por: Corper, H. J., et al.
Publicado: (1946)

Ionic Interpretation of Drug Action in Chemotherapeutic Research
Publicado: (1956)

Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
por: Liu, Rong, et al.
Publicado: (2017)

Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics
por: Hariani, Gunjan D, et al.
Publicado: (2014)

Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021)

STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics
por: de Haas, Nienke, et al.
Publicado: (2019)

First and Second Line Chemotherapeutic Regimens for Non-Small Cell Lung Carcinomas - The Efficacy of Platinum, Non-Platinum and Combination Therapy: A Literature Review
por: Michael, Anita, et al.
Publicado: (2020)

Effect of Dicycloplatin, a Novel Platinum Chemotherapeutical Drug, on Inhibiting Cell Growth and Inducing Cell Apoptosis
por: Li, Guang-quan, et al.
Publicado: (2012)

Erratum to: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics
por: Hariani, Gunjan D, et al.
Publicado: (2014)

Characterization in Dual Activation by Oxaliplatin, a Platinum-Based Chemotherapeutic Agent of Hyperpolarization-Activated Cation and Electroporation-Induced Currents
por: Chang, Wei-Ting, et al.
Publicado: (2020)

Chemotherapeutic Studies on Plasmodium Infection in Monkeys: No. V. Action of Tebetren
por: Chopra, R. N., et al.
Publicado: (1935)

Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study
por: Srivastava, Varshita, et al.
Publicado: (2023)

Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics
por: Lee, Michelle H., et al.
Publicado: (2019)

The mode of action of cis dichloro-bis (isopropylamine) trans dihydroxy platinum IV (CHIP) studied by the analysis of chromosome aberration production.
por: Bocian, E., et al.
Publicado: (1983)

Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
por: Hounkpatin, Aurore B, et al.
Publicado: (2019)

Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea
por: Kim, Kyoung Kon
Publicado: (2019)

Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
por: Herůdková, Jarmila, et al.
Publicado: (2017)

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
por: Jeerakornpassawat, Dhammapoj, et al.
Publicado: (2020)

FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum‐Containing Chemotherapy
por: Ning, Yang‐Min, et al.
Publicado: (2017)

Modulation of Glutamate Transporter EAAT1 and Inward-Rectifier Potassium Channel K(ir4.1) Expression in Cultured Spinal Cord Astrocytes by Platinum-Based Chemotherapeutics
por: Leo, Markus, et al.
Publicado: (2021)

Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography.
por: Tokuchi, Y., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_0a0o5vv0v8gja03n1p2g96p59s